{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:08:18Z","timestamp":1791101298344,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00467-010-1736-2","type":"journal-article","created":{"date-parts":[[2011,1,3]],"date-time":"2011-01-03T17:41:09Z","timestamp":1294076469000},"page":"2099-2109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Sickle cell nephropathy: challenging the conventional wisdom"],"prefix":"10.1007","volume":"26","author":[{"given":"Amy M.","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archinte.1990.00390150015003","volume":"150","author":"M Allon","year":"1990","unstructured":"Allon M (1990) Renal abnormalities in sickle cell disease. Arch Intern Med 150:501\u2013504","journal-title":"Arch Intern Med"},{"key":"1736_CR2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1046\/j.1523-1755.2002.00363.x","volume":"61","author":"DE Wesson","year":"2002","unstructured":"Wesson DE (2002) The initiation and progression of sickle cell nephropathy. Kidney Int 61:2277\u20132286","journal-title":"Kidney Int"},{"key":"1736_CR3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","volume":"115","author":"DR Powars","year":"1991","unstructured":"Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C (1991) Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 115:614\u2013620","journal-title":"Ann Intern Med"},{"key":"1736_CR4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","volume":"84","author":"DR Powars","year":"2005","unstructured":"Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Med Baltim 84:363\u2013376","journal-title":"Med Baltim"},{"key":"1736_CR5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(70)90836-6","volume":"1","author":"LW Statius van Eps","year":"1970","unstructured":"Statius van Eps LW, Pinedo-Veels C, de Vries GH, de Koning J (1970) Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet 1:450\u2013452","journal-title":"Lancet"},{"key":"1736_CR6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ki.1988.209","volume":"34","author":"M Allon","year":"1988","unstructured":"Allon M, Lawson L, Eckman JR, Delaney V, Bourke E (1988) Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia. Kidney Int 34:500\u2013506","journal-title":"Kidney Int"},{"key":"1736_CR7","first-page":"212","volume":"22","author":"PE de Jong","year":"1984","unstructured":"de Jong PE, Saleh AW, de Zeeuw D, Donker AJ, van der Hem GK, Pratt JJ, Sewrajsingh GS, Statius van Eps LW (1984) Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity? Clin Nephrol 22:212\u2013213","journal-title":"Clin Nephrol"},{"key":"1736_CR8","first-page":"185","volume":"83","author":"JN Etteldorf","year":"1952","unstructured":"Etteldorf JN, Tuttle AW, Clayton GW (1952) Renal function studies in pediatrics. 1. Renal hemodynamics in children with sickle cell anemia. AMA Am J Dis Child 83:185\u2013191","journal-title":"AMA Am J Dis Child"},{"key":"1736_CR9","first-page":"749","volume":"136","author":"DR Wigfall","year":"2000","unstructured":"Wigfall DR, Ware RE, Burchinal MR, Kinney TR, Foreman JW (2000) Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 136:749\u2013753","journal-title":"J Pediatr"},{"key":"1736_CR10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s004670050491","volume":"12","author":"VR Dharnidharka","year":"1998","unstructured":"Dharnidharka VR, Dabbagh S, Atiyeh B, Simpson P, Sarnaik S (1998) Prevalence of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 12:475\u2013478","journal-title":"Pediatr Nephrol"},{"key":"1736_CR11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00043426-200208000-00013","volume":"24","author":"PG McBurney","year":"2002","unstructured":"McBurney PG, Hanevold CD, Hernandez CM, Waller JL, McKie KM (2002) Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol 24:473\u2013477","journal-title":"J Pediatr Hematol Oncol"},{"key":"1736_CR12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPH.0b013e3180335081","volume":"29","author":"KT McKie","year":"2007","unstructured":"McKie KT, Hanevold CD, Hernandez C, Waller JL, Ortiz L, McKie KM (2007) Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J Pediatr Hematol Oncol 29:140\u2013144","journal-title":"J Pediatr Hematol Oncol"},{"key":"1736_CR13","unstructured":"Diabetic Nephropathy (2008) In: Brenner BM (ed) Brenner & Rector's the kidney. 8th edn. Saunders, pp 1265\u20131290"},{"key":"1736_CR14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2009.11.021","volume":"55","author":"F Turgut","year":"2010","unstructured":"Turgut F, Bolton WK (2010) Potential new therapeutic agents for diabetic kidney disease. Am J Kidney Dis 55:928\u2013940","journal-title":"Am J Kidney Dis"},{"key":"1736_CR15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajh.21016","volume":"83","author":"VR Gordeuk","year":"2008","unstructured":"Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, Castro OL (2008) Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol 83:15\u201318","journal-title":"Am J Hematol"},{"key":"1736_CR16","doi-asserted-by":"crossref","unstructured":"Rincon-Choles H, Kasinath BS, Gorin Y, Abboud HE (2002) Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy. Kidney Int Suppl S8-11","DOI":"10.1046\/j.1523-1755.62.s82.3.x"},{"key":"1736_CR17","first-page":"512","volume":"86","author":"WW McCrory","year":"1953","unstructured":"McCrory WW, Goren N, Gornfeld D (1953) Demonstration of impairment of urinary concentration ability, or pitressin-resistance, in children with sickle-cell anemia. AMA Am J Dis Child 86:512\u2013515","journal-title":"AMA Am J Dis Child"},{"key":"1736_CR18","first-page":"352","volume":"13","author":"HW Kunz","year":"1954","unstructured":"Kunz HW, Pratt EL, Mellin GW, Cheung MW (1954) Impairment of urinary concentration in sickle cell anemia. Pediatrics 13:352\u2013356","journal-title":"Pediatrics"},{"key":"1736_CR19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI103360","volume":"35","author":"HA Itano","year":"1956","unstructured":"Itano HA, Keitel HG, Thompson D (1956) Hyposthenuria in sickle cell anemia: a reversible renal defect. J Clin Invest 35:998\u20131007","journal-title":"J Clin Invest"},{"key":"1736_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/cs0630053","volume":"63","author":"PE de Jong","year":"1982","unstructured":"de Jong PE, de Jong-van Den Berg LT, De Zeeuw D, Donker AJ, Schouten H, Statius van Eps LW (1982) The influence of indomethacin on renal concentrating and diluting capacity in sickle cell nephropathy. Clin Sci Lond 63:53\u201358","journal-title":"Clin Sci Lond"},{"key":"1736_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/pbc.22189","volume":"54","author":"ST Miller","year":"2010","unstructured":"Miller ST, Wang WC, Iyer R, Rana S, Lane P, Ware RE, Li D, Rees RC (2010) Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG). Pediatr Blood Cancer 54:265\u2013268","journal-title":"Pediatr Blood Cancer"},{"key":"1736_CR22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(75)90528-8","volume":"58","author":"GR Zins","year":"1975","unstructured":"Zins GR (1975) Renal prostaglandins. Am J Med 58:14\u201324","journal-title":"Am J Med"},{"key":"1736_CR23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/cs0590245","volume":"59","author":"PE de Jong","year":"1980","unstructured":"de Jong PE, de Jong-Van Den Berg, Sewrajsingh GS, Schouten H, Donker AJ, Statius van Eps LW (1980) The influence of indomethacin on renal haemodynamics in sickle cell anaemia. Clin Sci Lond 59:245\u2013250","journal-title":"Clin Sci Lond"},{"key":"1736_CR24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ki.1996.301","volume":"50","author":"N Bank","year":"1996","unstructured":"Bank N, Aynedjian HS, Qiu JH, Osei SY, Ahima RS, Fabry ME, Nagel RL (1996) Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int 50:184\u2013189","journal-title":"Kidney Int"},{"key":"1736_CR25","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1046\/j.1523-1755.1998.00148.x","volume":"54","author":"N Bank","year":"1998","unstructured":"Bank N, Kiroycheva M, Ahmed F, Anthony GM, Fabry ME, Nagel RL, Singhal PC (1998) Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int 54:1520\u20131528","journal-title":"Kidney Int"},{"key":"1736_CR26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1523-1755.2000.00143.x","volume":"58","author":"N Bank","year":"2000","unstructured":"Bank N, Kiroycheva M, Singhal PC, Anthony GM, Southan GJ, Szabo C (2000) Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int 58:82\u201389","journal-title":"Kidney Int"},{"key":"1736_CR27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00467-003-1271-5","volume":"18","author":"G Filler","year":"2003","unstructured":"Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981\u2013985","journal-title":"Pediatr Nephrol"},{"key":"1736_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.ajkd.2006.04.085","volume":"48","author":"M Zappitelli","year":"2006","unstructured":"Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, Bell L (2006) Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis 48:221\u2013230","journal-title":"Am J Kidney Dis"},{"key":"1736_CR29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pbc.22269","volume":"54","author":"BW Thompson","year":"2010","unstructured":"Thompson BW, Miller ST, Rogers ZR, Rees RC, Ware RE, Waclawiw MA, Iyer RV, Casella JF, Luchtman-Jones L, Rana S, Thornburg CD, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik S, Howard TH, Luck L, Wang WC (2010) The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer 54:250\u2013255","journal-title":"Pediatr Blood Cancer"},{"key":"1736_CR30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2009.06.060","volume":"156","author":"RE Ware","year":"2010","unstructured":"Ware RE, Rees RC, Sarnaik SA, Iyer RV, Alvarez OA, Casella JF, Shulkin BL, Shalaby-Rana E, Strife CF, Miller JH, Lane PA, Wang WC, Miller ST (2010) Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J Pediatr 156:66\u201370","journal-title":"J Pediatr"},{"key":"1736_CR31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/pbc.22516","volume":"54","author":"W Wang","year":"2010","unstructured":"Wang W, Thompson B, BABY HUG Investigators (2010) Hydroxyurea Treatment of Infants with Sickle Cell Anemia: Results of the BABY HUG Study. Pediatr Blood Cancer 54:787","journal-title":"Pediatr Blood Cancer"},{"key":"1736_CR32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pbc.21738","volume":"52","author":"CD Thornburg","year":"2009","unstructured":"Thornburg CD, Dixon N, Burgett S, Mortier NA, Schultz WH, Zimmerman SA, Bonner M, Hardy KK, Calatroni A, Ware RE (2009) A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer 52:609\u2013615","journal-title":"Pediatr Blood Cancer"},{"key":"1736_CR33","doi-asserted-by":"crossref","unstructured":"Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE (2009) Glomerular hyperfiltration and microalbuminuria in children with sickle cell anemia. Blood 114: Abstract 263","DOI":"10.1182\/blood.V114.22.263.263"},{"key":"1736_CR34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pbc.20645","volume":"47","author":"O Alvarez","year":"2006","unstructured":"Alvarez O, Montane B, Lopez G, Wilkinson J, Miller T (2006) Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer 47:71\u201376","journal-title":"Pediatr Blood Cancer"},{"key":"1736_CR35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5414\/CNP57127","volume":"57","author":"AK Bayazit","year":"2002","unstructured":"Bayazit AK, Noyan A, Aldudak B, Ozel A, Anarat A, Kilinc Y, Sasmaz GE, Anarat R, Dikmen N (2002) Renal function in children with sickle cell anemia. Clin Nephrol 57:127\u2013130","journal-title":"Clin Nephrol"},{"key":"1736_CR36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75:652\u2013660","journal-title":"Kidney Int"},{"key":"1736_CR37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","volume":"65","author":"EL Knight","year":"2004","unstructured":"Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416\u20131421","journal-title":"Kidney Int"},{"key":"1736_CR38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cccn.2003.07.022","volume":"338","author":"P Wiesli","year":"2003","unstructured":"Wiesli P, Schwegler B, Spinas GA, Schmid C (2003) Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 338:87\u201390","journal-title":"Clin Chim Acta"},{"key":"1736_CR39","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1681\/ASN.2005050512","volume":"16","author":"C White","year":"2005","unstructured":"White C, Akbari A, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA (2005) Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol 16:3763\u20133770","journal-title":"J Am Soc Nephrol"},{"key":"1736_CR40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00467-006-0033-6","volume":"21","author":"O Alvarez","year":"2006","unstructured":"Alvarez O, Zilleruelo G, Wright D, Montane B, Lopez-Mitnik G (2006) Serum cystatin C levels in children with sickle cell disease. Pediatr Nephrol 21:533\u2013537","journal-title":"Pediatr Nephrol"},{"key":"1736_CR41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/ajkd.1998.v32.pm9708603","volume":"32","author":"F Schmitt","year":"1998","unstructured":"Schmitt F, Martinez F, Brillet G, Giatras I, Choukroun G, Girot R, Bachir D, Galacteros F, Lacour B, Grunfeld JP (1998) Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis 32:208\u2013214","journal-title":"Am J Kidney Dis"},{"key":"1736_CR42","first-page":"632","volume":"76","author":"FE Hatch Jr","year":"1970","unstructured":"Hatch FE Jr, Azar SH, Ainsworth TE, Nardo JM, Culbertson JW (1970) Renal circulatory studies in young adults with sickle cell anemia. J Lab Clin Med 76:632\u2013640","journal-title":"J Lab Clin Med"},{"key":"1736_CR43","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ki.1997.116","volume":"51","author":"A Guasch","year":"1997","unstructured":"Guasch A, Cua M, You W, Mitch WE (1997) Sickle cell anemia causes a distinct pattern of glomerular dysfunction. Kidney Int 51:826\u2013833","journal-title":"Kidney Int"},{"key":"1736_CR44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archinte.167.7.701","volume":"167","author":"J Thompson","year":"2007","unstructured":"Thompson J, Reid M, Hambleton I, Serjeant GR (2007) Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study. Arch Intern Med 167:701\u2013708","journal-title":"Arch Intern Med"},{"key":"1736_CR45","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","volume":"17","author":"A Guasch","year":"2006","unstructured":"Guasch A, Navarrete J, Nass K, Zayas CF (2006) Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17:2228\u20132235","journal-title":"J Am Soc Nephrol"},{"key":"1736_CR46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1681\/ASN.V1111241","volume":"1","author":"DB Bhathena","year":"1991","unstructured":"Bhathena DB, Sondheimer JH (1991) The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis. J Am Soc Nephrol 1:1241\u20131252","journal-title":"J Am Soc Nephrol"},{"key":"1736_CR47","first-page":"407","volume":"70","author":"J Bernstein","year":"1960","unstructured":"Bernstein J, Whitten CF (1960) A histologic appraisal of the kidney in sickle cell anemia. Arch Pathol 70:407\u2013418","journal-title":"Arch Pathol"},{"key":"1736_CR48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/sj.ki.5000248","volume":"69","author":"E Voskaridou","year":"2006","unstructured":"Voskaridou E, Terpos E, Michail S, Hantzi E, Anagnostopoulos A, Margeli A, Simirloglou D, Loukopoulos D, Papassotiriou I (2006) Early markers of renal dysfunction in patients with sickle cell\/beta-thalassemia. Kidney Int 69:2037\u20132042","journal-title":"Kidney Int"},{"key":"1736_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jcp.2005.026799","volume":"59","author":"R Marouf","year":"2006","unstructured":"Marouf R, Mojiminiyi O, Abdella N, Kortom M, Al Wazzan H (2006) Comparison of renal function markers in Kuwaiti patients with sickle cell disease. J Clin Pathol 59:345\u2013351","journal-title":"J Clin Pathol"},{"key":"1736_CR50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02723586","volume":"70","author":"V Datta","year":"2003","unstructured":"Datta V, Ayengar JR, Karpate S, Chaturvedi P (2003) Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease. Indian J Pediatr 70:307\u2013309","journal-title":"Indian J Pediatr"},{"key":"1736_CR51","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1590\/S0100-879X1998001000004","volume":"31","author":"R Sesso","year":"1998","unstructured":"Sesso R, Almeida MA, Figueiredo MS, Bordin JO (1998) Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz J Med Biol Res 31:1257\u20131262","journal-title":"Braz J Med Biol Res"},{"key":"1736_CR52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199204023261402","volume":"326","author":"RJ Falk","year":"1992","unstructured":"Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC (1992) Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 326:910\u2013915","journal-title":"N Engl J Med"},{"key":"1736_CR53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000167444","volume":"7","author":"AA Bakir","year":"1987","unstructured":"Bakir AA, Hathiwala SC, Ainis H, Hryhorczuk DO, Rhee HL, Levy PS, Dunea G (1987) Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. Am J Nephrol 7:110\u2013115","journal-title":"Am J Nephrol"},{"key":"1736_CR54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5414\/CNP58009","volume":"58","author":"KC Abbott","year":"2002","unstructured":"Abbott KC, Hypolite IO, Agodoa LY (2002) Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 58:9\u201315","journal-title":"Clin Nephrol"},{"key":"1736_CR55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00007890-199901270-00018","volume":"67","author":"AO Ojo","year":"1999","unstructured":"Ojo AO, Govaerts TC, Schmouder RL, Leichtman AB, Leavey SF, Wolfe RA, Held PJ, Port FK, Agodoa LY (1999) Renal transplantation in end-stage sickle cell nephropathy. Transplantation 67:291\u2013295","journal-title":"Transplantation"},{"key":"1736_CR56","first-page":"130","volume":"2","author":"BA Warady","year":"1998","unstructured":"Warady BA, Sullivan EK (1998) Renal transplantation in children with sickle cell disease: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2:130\u2013133","journal-title":"Pediatr Transplant"},{"key":"1736_CR57","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0961203309356291","volume":"19","author":"M Cherner","year":"2010","unstructured":"Cherner M, Isenberg D (2010) The overlap of systemic lupus erythematosus and sickle cell disease: report of two cases and a review of the literature. Lupus 19:875\u2013883","journal-title":"Lupus"},{"key":"1736_CR58","first-page":"3","volume":"92","author":"RA Willson","year":"1997","unstructured":"Willson RA (1997) Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 92:3\u201317","journal-title":"Am J Gastroenterol"},{"key":"1736_CR59","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0272-6386(03)00828-X","volume":"42","author":"CM Meyers","year":"2003","unstructured":"Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH (2003) Hepatitis C and renal disease: an update. Am J Kidney Dis 42:631\u2013657","journal-title":"Am J Kidney Dis"},{"key":"1736_CR60","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0027-9684(15)31131-7","volume":"101","author":"SE Buskin","year":"2009","unstructured":"Buskin SE, Torno MS, Talkington DF, Zhang M, Jones JL, Butler JC, McNaghten AD, Dworkin MS (2009) Trends in nephropathy among HIV-infected patients. J Natl Med Assoc 101:1205\u20131213","journal-title":"J Natl Med Assoc"},{"key":"1736_CR61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2215\/CJN.00300106","volume":"1","author":"JA Jaffe","year":"2006","unstructured":"Jaffe JA, Kimmel PL (2006) Chronic nephropathies of cocaine and heroin abuse: a critical review. Clin J Am Soc Nephrol 1:655\u2013667","journal-title":"Clin J Am Soc Nephrol"},{"key":"1736_CR62","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0002-9343(99)80341-6","volume":"98","author":"RY Aoki","year":"1995","unstructured":"Aoki RY, Saad ST (1995) Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med 98:432\u2013435","journal-title":"Am J Med"},{"key":"1736_CR63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9343(98)00056-4","volume":"104","author":"L Foucan","year":"1998","unstructured":"Foucan L, Bourhis V, Bangou J, Merault L, Etienne-Julan M, Salmi RL (1998) A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am J Med 104:339\u2013342","journal-title":"Am J Med"},{"key":"1736_CR64","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/pbc.20296","volume":"45","author":"CD Fitzhugh","year":"2005","unstructured":"Fitzhugh CD, Wigfall DR, Ware RE (2005) Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr Blood Cancer 45:982\u2013985","journal-title":"Pediatr Blood Cancer"},{"key":"1736_CR65","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-9343(82)90809-9","volume":"72","author":"D Batlle","year":"1982","unstructured":"Batlle D, Itsarayoungyuen K, Arruda JA, Kurtzman NA (1982) Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies. Am J Med 72:188\u2013192","journal-title":"Am J Med"},{"key":"1736_CR66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(96)00407-X","volume":"102","author":"CH Pegelow","year":"1997","unstructured":"Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E (1997) Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 102:171\u2013177","journal-title":"Am J Med"},{"key":"1736_CR67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000441-199303000-00004","volume":"305","author":"GP Rodgers","year":"1993","unstructured":"Rodgers GP, Walker EC, Podgor MJ (1993) Is \"relative\" hypertension a risk factor for vaso-occlusive complications in sickle cell disease? Am J Med Sci 305:150\u2013156","journal-title":"Am J Med Sci"},{"key":"1736_CR68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00041552-200301000-00010","volume":"12","author":"MR Weir","year":"2003","unstructured":"Weir MR, Blantz RC (2003) Blood pressure and cardiovascular risks: implications of the presence or absence of a nocturnal dip in blood pressure. Curr Opin Nephrol Hypertens 12:57\u201360","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1736_CR69","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/HYPERTENSIONAHA.106.084343","volume":"49","author":"F Sayk","year":"2007","unstructured":"Sayk F, Becker C, Teckentrup C, Fehm HL, Struck J, Wellhoener JP, Dodt C (2007) To dip or not to dip: on the physiology of blood pressure decrease during nocturnal sleep in healthy humans. Hypertension 49:1070\u20131076","journal-title":"Hypertension"},{"key":"1736_CR70","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa013410","volume":"347","author":"E Lurbe","year":"2002","unstructured":"Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D (2002) Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347:797\u2013805","journal-title":"N Engl J Med"},{"key":"1736_CR71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ajh\/7.1.23","volume":"7","author":"S Bianchi","year":"1994","unstructured":"Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM (1994) Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 7:23\u201329","journal-title":"Am J Hypertens"},{"key":"1736_CR72","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1523-1755.2004.00419.x","volume":"65","author":"M Fukuda","year":"2004","unstructured":"Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, Yoshida A, Kimura G (2004) Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 65:621\u2013625","journal-title":"Kidney Int"},{"key":"1736_CR73","first-page":"2","volume":"3","author":"A Gabriel","year":"2010","unstructured":"Gabriel A, Przybylski J (2010) Sickle cell anemia: a look at global haplotype distribution. Nat Educ 3:2","journal-title":"Nat Educ"},{"key":"1736_CR74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H, Nangaku M, Navar LG, Nishiyama A (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59:251\u2013287","journal-title":"Pharmacol Rev"},{"key":"1736_CR75","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MAJ.0b013e3181b90c25","volume":"338","author":"T Saito","year":"2009","unstructured":"Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H (2009) Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 338:478\u2013480","journal-title":"Am J Med Sci"},{"key":"1736_CR76","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2741\/1853","volume":"11","author":"R Sharma","year":"2006","unstructured":"Sharma R, Sharma M, Reddy S, Savin VJ, Nagaria AM, Wiegmann TB (2006) Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes. Front Biosci 11:968\u2013976","journal-title":"Front Biosci"},{"key":"1736_CR77","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1681\/ASN.2006060554","volume":"18","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, Kato A, Nakamura Y, Suzuki F, Hishida A (2007) Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 18:1558\u20131565","journal-title":"J Am Soc Nephrol"},{"key":"1736_CR78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/HYPERTENSIONAHA.108.123802","volume":"53","author":"H Kobori","year":"2009","unstructured":"Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG (2009) Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension 53:344\u2013350","journal-title":"Hypertension"},{"key":"1736_CR79","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1542\/peds.5.1.127","volume":"5","author":"PL Calcagno","year":"1950","unstructured":"Calcagno PL, McLavy J, Kelley T (1950) Glomerular filtration rate in children with sickle cell disease. Pediatrics 5:127\u2013129","journal-title":"Pediatrics"},{"key":"1736_CR80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0002-9343(55)90239-4","volume":"18","author":"JN Etteldorf","year":"1955","unstructured":"Etteldorf JN, Smith JD, Tuttle AH, Diggs LW (1955) Renal hemodynamic studies in adults with sickle cell anemia. Am J Med 18:243\u2013248","journal-title":"Am J Med"},{"key":"1736_CR81","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jcp.43.5.370","volume":"43","author":"SA Aparicio","year":"1990","unstructured":"Aparicio SA, Mojiminiyi S, Kay JD, Shepstone BJ, de Ceulaer K, Serjeant GR (1990) Measurement of glomerular filtration rate in homozygous sickle cell disease: a comparison of 51Cr-EDTA clearance, creatinine clearance, serum creatinine and beta 2 microglobulin. J Clin Pathol 43:370\u2013372","journal-title":"J Clin Pathol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1736-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-010-1736-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1736-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-010-1736-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T18:21:14Z","timestamp":1685902874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-010-1736-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1007\/s00467-010-1736-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"4 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}